MaaT Pharma Reports Financial Results for the Third Quarter 2026
Revenues of EUR 0.5 million in the third quarter of 2026 and EUR 1.6 million year-to-date, derived f
Revenues of EUR 0.5 million in the third quarter of 2026 and EUR 1.6 million year-to-date, derived f